The effect of danazol on the circulating levels of 34K insulin-like growth factor-binding protein (PP12) and endometrial secretory protein PP14

G. Than, M. Seppälä, M. Julkunen, D. Szabo, J. Bodis, A. Szilagyi, I. Csaba

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Twenty-four women, 11 with endometriosis and 13 with fibrocystic mastopathy, were treated with a medium dose (300-400 mg daily) of Danazol for 6 months. The circulating level of progesterone, the 34K insulin-like growth factor-binding protein (IGF-bp) and endometrial protein PP14 (placental protein 14) were measured by specific radioimmunoassays before and during treatment. The serum progesterone concentration decreased significantly during Danazol treatment, as did the serum levels of 34K IGF-bp and PP14. By the third month of therapy amenorrhoea was observed in 22 out of 24 women and this was accompanied by a further decline in the IGF-bp and PP14 levels. In light of the previous observations on the IGF-bp and PP14 synthesis by secretory endometrium and the fact that Danazol causes endometrial atrophy, these results suggest that Danazol treatment has an effect on endometrial protein secretion.

Original languageEnglish
Pages (from-to)549-551
Number of pages3
JournalHuman Reproduction
Volume2
Issue number7
Publication statusPublished - Oct 1987

Fingerprint

Pregnancy Proteins
Danazol
Insulin-Like Growth Factor Binding Proteins
Insulin
Growth Factors
Proteins
Protein
Progesterone
Fibrocystic Breast Disease
Amenorrhea
Endometriosis
Therapeutics
Endometrium
Serum
Atrophy
Radioimmunoassay
Carrier Proteins
Intercellular Signaling Peptides and Proteins
Growth factors
Protein Synthesis

Keywords

  • Danazol
  • Endometrial proteins
  • Insulin-like growth factor-binding protein
  • Placental protein 12
  • Placental protein 14

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Reproductive Medicine
  • Obstetrics and Gynaecology
  • Rehabilitation
  • Developmental Biology
  • Physiology

Cite this

The effect of danazol on the circulating levels of 34K insulin-like growth factor-binding protein (PP12) and endometrial secretory protein PP14. / Than, G.; Seppälä, M.; Julkunen, M.; Szabo, D.; Bodis, J.; Szilagyi, A.; Csaba, I.

In: Human Reproduction, Vol. 2, No. 7, 10.1987, p. 549-551.

Research output: Contribution to journalArticle

Than, G. ; Seppälä, M. ; Julkunen, M. ; Szabo, D. ; Bodis, J. ; Szilagyi, A. ; Csaba, I. / The effect of danazol on the circulating levels of 34K insulin-like growth factor-binding protein (PP12) and endometrial secretory protein PP14. In: Human Reproduction. 1987 ; Vol. 2, No. 7. pp. 549-551.
@article{c9c7c9aadba8430f8040daece7e87c1d,
title = "The effect of danazol on the circulating levels of 34K insulin-like growth factor-binding protein (PP12) and endometrial secretory protein PP14",
abstract = "Twenty-four women, 11 with endometriosis and 13 with fibrocystic mastopathy, were treated with a medium dose (300-400 mg daily) of Danazol for 6 months. The circulating level of progesterone, the 34K insulin-like growth factor-binding protein (IGF-bp) and endometrial protein PP14 (placental protein 14) were measured by specific radioimmunoassays before and during treatment. The serum progesterone concentration decreased significantly during Danazol treatment, as did the serum levels of 34K IGF-bp and PP14. By the third month of therapy amenorrhoea was observed in 22 out of 24 women and this was accompanied by a further decline in the IGF-bp and PP14 levels. In light of the previous observations on the IGF-bp and PP14 synthesis by secretory endometrium and the fact that Danazol causes endometrial atrophy, these results suggest that Danazol treatment has an effect on endometrial protein secretion.",
keywords = "Danazol, Endometrial proteins, Insulin-like growth factor-binding protein, Placental protein 12, Placental protein 14",
author = "G. Than and M. Sepp{\"a}l{\"a} and M. Julkunen and D. Szabo and J. Bodis and A. Szilagyi and I. Csaba",
year = "1987",
month = "10",
language = "English",
volume = "2",
pages = "549--551",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - The effect of danazol on the circulating levels of 34K insulin-like growth factor-binding protein (PP12) and endometrial secretory protein PP14

AU - Than, G.

AU - Seppälä, M.

AU - Julkunen, M.

AU - Szabo, D.

AU - Bodis, J.

AU - Szilagyi, A.

AU - Csaba, I.

PY - 1987/10

Y1 - 1987/10

N2 - Twenty-four women, 11 with endometriosis and 13 with fibrocystic mastopathy, were treated with a medium dose (300-400 mg daily) of Danazol for 6 months. The circulating level of progesterone, the 34K insulin-like growth factor-binding protein (IGF-bp) and endometrial protein PP14 (placental protein 14) were measured by specific radioimmunoassays before and during treatment. The serum progesterone concentration decreased significantly during Danazol treatment, as did the serum levels of 34K IGF-bp and PP14. By the third month of therapy amenorrhoea was observed in 22 out of 24 women and this was accompanied by a further decline in the IGF-bp and PP14 levels. In light of the previous observations on the IGF-bp and PP14 synthesis by secretory endometrium and the fact that Danazol causes endometrial atrophy, these results suggest that Danazol treatment has an effect on endometrial protein secretion.

AB - Twenty-four women, 11 with endometriosis and 13 with fibrocystic mastopathy, were treated with a medium dose (300-400 mg daily) of Danazol for 6 months. The circulating level of progesterone, the 34K insulin-like growth factor-binding protein (IGF-bp) and endometrial protein PP14 (placental protein 14) were measured by specific radioimmunoassays before and during treatment. The serum progesterone concentration decreased significantly during Danazol treatment, as did the serum levels of 34K IGF-bp and PP14. By the third month of therapy amenorrhoea was observed in 22 out of 24 women and this was accompanied by a further decline in the IGF-bp and PP14 levels. In light of the previous observations on the IGF-bp and PP14 synthesis by secretory endometrium and the fact that Danazol causes endometrial atrophy, these results suggest that Danazol treatment has an effect on endometrial protein secretion.

KW - Danazol

KW - Endometrial proteins

KW - Insulin-like growth factor-binding protein

KW - Placental protein 12

KW - Placental protein 14

UR - http://www.scopus.com/inward/record.url?scp=0023522654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023522654&partnerID=8YFLogxK

M3 - Article

C2 - 3680485

AN - SCOPUS:0023522654

VL - 2

SP - 549

EP - 551

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 7

ER -